Skip to content
Homepage
Author:
Vivex Biologics, Inc.
Posted Date:
July 22, 2026
Vivex Biologics Launches VIA Linx™, a Novel Self-Assembling Synthetic Peptide Matrix, Expanding its Portfolio of Advanced Wound Care Solutions
Vivex Biologics, Inc.
July 22, 2026
Vivex Biologics Publishes New Medicare Real-World Evidence Study Showing VIA Disc® NP Significantly Reduces Opioid Use, Imaging, and Conservative Care Utilization in Patients with Lumbar Discogenic Pain
Vivex Biologics, Inc.
June 5, 2026
